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TCRs are cell surface heterodimers of variable a and /3 chains that mediate T
cell recognition of peptide antigens as presented byMHC proteins . The structural
features of this interaction are still poorly understood . It is likely that amino acid
residues from both the peptide and theMHC molecule contact with theTCR (1-3).
Thus, MHC protein polymorphism may contribute to the specificity of T cell rec-
ognition by modulating direct interaction with the TCR and peptide binding.
TCR variability is generated, in both a anda chains, by the combinatorial rear-
rangement of multiple germline-encoded V D (for the ,Q chain), andJ gene seg-
ments, through mechanisms that allow introduction of great diversity at thefunc-
tional regions (4, 5) .
The TCR might adopt an Ig-like folding . The equivalents, in the TCR, to the
complementarity-determining regions (CDR)' 1 and 2 from Igs would be encoded
in the Vu and V/3 gene segments and would presumably contact with residues in
the a helices of the MHC molecule ; the CDR3-equivalents would correspond to
the junctional regions and would interact mainly with bound peptide (3, 6) .
The clonal heterogeneity ofT cell alloreactive responses is highly complex (7).
Inhumans, an extremely diverse spectrum ofspecificitieshas been revealed by anal-
yses of CTL clones with structurally defined HLA mutants (8-10) . A possible in-
terpretation ofsuch diversity is that alloreactive T cells mightrecognize alloantigen-
boundpeptides . This is supported by mounting evidence (11-15). Indeed, availability
of peptide ligands may be required for correct folding of class I MHC molecules
and for their transport to the cell surface (16) . The question remains as to whether
the complexity of allospecific responses can be understood in terms of sets of epi-
topes sharing some structural features . If so, one may ask whether such epitopes
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are recognized by related TCR structures and what is the molecular basis of this
relatedness.
To address these questions, we have examined the structure ofthe V/3 genes used
by a series of alloreactive CTL clones against HLA-B27, whose fine specificity was
previously established. A strategy, basedon specific amplificationanddirect sequencing
of V(3 genes, was used . The results suggest a nonrandom Va gene diversity in the
alloreactive CTL response against HLA-B27.
Materials and Methods
TCell Clones.
￿
12 human HLA-B27-specific CTLclones were used in this study. 11 of these
clones were raised from four different HLA-B27- individuals against the B*2705' lympho-
blastoid cell lines (LCL) LG15 (HLA-A32 ; B*2705) or R69 (HLA-A3, 24; B*2705, 7). The
followinganti-B*2705 CTL clones were derived from each responder: from donorPA (HLA-
A24, w33; B35,39), CTL 28 and 40 (17); from donor DL (HLA-A29, 31; B39, 44), CTL
64DRF, 67DRF, 102DRF, 172DRF, and 212DRD; from donor GM (HLA-Al, 24; B7, 8),
CTL GM7, 5A2, and 17A2; from donor BG (HLA-A2; B5, 7), CTL G36 (10). One addi-
tional clone, CTL 64.8P, was obtained from yet another HLA-B27- individual against a
B*2704' LCL (18). In addition, eight CTL clones not reactive with HLA-B27, but other-
wise uncharacterized, were used. Thesewere CTL 1DRD, 14DRD, 17DRD, 223DRD, 55DRF,
166DRF (all from donor DL), M42 (from donor GM), and G21 (from donor BG).
All clones were derived by limiting dilution as described (19). Cellswere cloned after pri-
mary, secondary, or tertiary (for 64.8P) MLC and were selected, amongthose with lytic ac-
tivity against the stimulator LCL, for their capacity to lyse B*2705' HMy2.CIR transfec-
tant cells, but not the same cells transfected only with pSV2neo, at an E/T ratio of4:1 (10).
HMy2CIR (a gift ofDr.P Creswell, Duke University, Durham, NC)is aclassIMHC-deficient
mutant derived from the human plasma cell leukemia line LICR.LON.HMy2 (20).
The fine specificity of the anti-HLA-B27 CTLclones was established: (a) by panelanalysis
with LCLexpressing all sixstructurally characterized HLA-B27 subtypes, B*2701 to B*2706
(21), and multiple HLA-B27- LCL; (b) by using a panel of HMy2.CIR transfectants ex-
pressing HLA-B*2705, B*2702 andnine site-specific B*2705 mutants, most ofthem mimicking,
at one or at two positions, changes occurring in the HLA-B27 subtypes (10). A standard "Cr
release cytotoxicity assay was used (19).
The anti-B*2705 CTL clones could be classified into three groups (Table I) on the basis
of their reactivity with HLA-B27 subtypes (10, 17). Group A included seven CTL clones
reacting only with B*2705. Group B included two CTL clones, reacting only with B*2705
and B*2703 . GroupC included two clones that reactedonly with B*2705 and B*2702. Thus,
none of the 11 anti-B*2705 CTL clones recognized B*2701, B*2704, or B*2706. The anti-
B*2704 CTLclone64.8Preacted with all B27 subtypes except B*2703 (18). Most CTLclones
were different from one another when tested with the mutants (10). The single exceptions
were CTL 67DRF (unpublished data) and 102 DRF, which were indistinguishable by this
criterium.
Pblymerase ChainReaction (PCR)andSequencing.
￿
TCR/3 chain mRNA from each CTLclone
was converted to cDNA, amplified, and reconverted to single-stranded templates for direct
DNA sequencing. This strategy required the steps described below.
The first step was specific PCR amplification of V0 cDNA. For each of the 20 described
V/3 families (5), an oligonucleotide with a sequence common to all known members from
that family, and different from available V(3 sequencesfrom otherfamilies, wasselected. The
only exceptions were the V013-specific oligonucleotide, which showed one mismatch with ,
one V013 member, andthe V08-specific primer,which presented one and two 5' end-located
mismatches, respectively, with two V08 members. An oligonucleotide, designated as 12a,
whose sequence wasshared by V,Q3, V012, Va13, V014, and V015, wasalso selected. Acom-
pilation of 49 different V/3 sequences (5) was used. The search was done in an HP Vectra
RS/25C computer usingthe Local(22; MolecularBiology Computer Research resource, Har-
vard School of Public Health, Boston, MA) and Pattern Matching (DNA and Protein Se-BRAGADO ET AL.
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quence Analysis Programs, version 4.3; Department of MolecularandCellular Biology, Univer-
sity of Arizona, Tucson, AR) programs. A value of four mismatches, including gaps, was
the minimum allowed disparity when comparing each family-specific oligonucleotide with
sequences from otherfamilies. As the only exception, the V06-specific oligonucleotide pos-
sessed three mismatches with VO16 members. In addition, aCO-specific oligonucleotide was
chosen to match a common sequence near the 5' ends of the C(31 and C(02 genes. The V(#-
and C,8-derived oligonucleotides were used as 5' sense and antisense primers, respectively,
forspecific PCR amplification ofV,QcDNA. These oligonucleotides were designated as "ex-
ternal" (E) and their sequences are given in Table II.
Total cytoplasmic RNA was isolated from each CTLcloneby a simplification ofastandard
technique (23). Briefly, pellets from 3 x 104 to 3 x 105 cells were lysed in 200 Al 10 mM
Tris-HCl, pH 7.6, 150 mM NaCl, 2 MM MgCl2 containing 0.5% NP-40 and 10 mM
vanadyl ribonucleoside complexes (BethesdaResearch Laboratories, Gaithersburg, MD). After
vortexing for 10 s, lysates were stored on ice for 5 min and then microfuged for 1 min at
4°C to pellet nuclei. Supernatants were added to an equal volume of 10 mM Tris-HCI, pH
7.6, 150 mM NaCl, 5 mM EDTA containing 1% SDS. Proteins were then removed by ex-
tracting several timeswith phenol/chloroform and once with chloroform, and the RNA was
precipitated by adding 3 M sodium acetate, pH 5.2, to a final concentration of 0.15 M and
2.2 Vol of ethanol. After storing at -70°C for 15 min, tubes were microfuged for 30 min
at 4°C. Pellets were allowed to dry at room temperature and a second precipitation was car-
ried out in 400 Al of 0.15 M sodium acetate, pH 5.2, by adding 880 141 ethanol.
To synthesize cDNA, the RNA was incubated at 42°C for 1 h with 50 Al of a reaction
mixture containing 1 AM C/3E oligonucleotide, dNTPs (Cetus Corp., Emeryville, CA), 200
AM each, 2 mM DTT, 2 Uhumanplacentalribonuclease inhibitor, and2 Uavianmyeloblas-
tosis virus reverse transcriptase(bothfrom BoeringerMannheim Biochemicals, Mannheim,
FRG) in 10 mM Tris-HCl, pH 8.3, 50 mM KCI, 1.5 MM MgC12, and 0.01% gelatin (Taq
buffer; Cetus Corp.).
After incubation, the reaction mixture was heated at 95°C for 5 min, to denature the
DNA/RNAcomplexes, cooled to 4°C, and8501A1 ofa solution containing C(OE oligonucleo-
tide and dNTPs at final concentrations of 1.1 AM and 220 AM each, in Taq buffer, respec-
tively, was added. 15 UofTaq polymerase (Cetus Corp.) was then added, and 45-Al aliquots
of this solution were transferred to 20 Eppendorf tubes, each containing 5 AI of 1 of the 20
V/OE family-specificoligonucleotides at 10-AM initialconcentration. Each reaction mixture
was overlaid with five drops of mineral oil and then subjected to 30 amplification cycles of
2 min at 95°C, 3.5 min at 39°C, and 2 min at 72°C, using a thermocycler (Hybaid Ltd.,
Middlesex, UK). After removing the layer of mineral oil, an aliquot of each amplification
reaction was loaded in a 2% agarose gel and run for 1 h at 100 V. Due to the small number
ofcells used forRNAisolation, ethidium bromide-stained bandswere notalways visualized.
To detect specific amplification products, alkaline Southern blots were carried out using Z
probe membrane (Bio-Rad Laboratories, Richmond, CA)as indicatedby the manufacturer.
The membrane was then washed for 2 min in 2x SSC (1 x SSC = 0.15 M NaCl/0.013 M
sodium citrate) andprehybridizeddirectly in 5x SSPE/10x Denhardt's solution/0.1% SDS/40
hg/ml salmon sperm DNA, for 45 min, at 5°C below the melting temperature (T.) of the
Col oligonucleotide(see below),to be used in thehybridization (1 x SSPE = 0.18 MNaCl/10
mM sodium phosphate, pH 7.4/1 mM EDTA and 1 x Denhardt's solution = 0.02% poly-
vinyl pyrrolidone/0.02% Ficoll/0.02% BSA). This oligonucleotide was labeled with (y-
[32P]dATP (5,000 Ci/mmol; Amersham International, Amersham, UK) by using polynucleo-
tide kinase (New England Biolabs, Beverly, MA). Unincorporated nucleotide was removed
by impregnating a Whatman DE81 paper with the labeling reaction mixture and washing
it with low-salt buffer (20mM Tris-HCl, pH 8, 1 mM EDTA, 0.1 M NaCl). Labeledmaterial
was recovered by eluting with high-salt buffer (20 mM Tris-HCl, pH 8, 1 mM EDTA, 1 M
NaCl). Blots were hybridized in the same solution as that used for prehybridization, except
that 5x Denhardt's wasused. Labeled oligonucleotide wasaddedat a concentration of 1 nM
and incubated for3 h at Tm -5°C. Blots were then washed three times in 6x SSC at room
temperature for 20 min, once in 6x SSC for 1 min at the hybridization temperature, and
exposed to Kodak X-Omat film.1192
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The second step was generation of single-stranded DNA and direct sequencing. New sets
ofVo- and Co-derivedoligonucleotides were selected as sense and antisense primers, respec-
tively, to perform asymmetric PCR on each strand of the PCRamplified cDNA, so that an
excess ofsingle-stranded DNA of a chosen strand was produced. This second set of oligonu-
cleotides was designated as "internal" (1), as they were matched to sequences located 3' and
5', respectively, from those ofthe VOE and C(OE primers used for the first PCR amplification.
Each of the Vol primers was chosen to match with all members of a given family, but mis-
match with other Vf3 families was not required at this stage. Asymmetric PCR amplification
was done as previously described (24, 25), using 10 nM VQE plus 1 pM C161 oligonucleotides
for the generation of the minus strand, and 1 pM Vol plus 10 nM COE oligonucleotides
for the generation of the positive strand. Direct sequencing of amplified DNA strands was
carried out as described (25), using the corresponding Vol oligonucleotide or the COI oligo-
nucleotide as primers for sequencingthe minus or the positive strand, respectively. The Col
oligonucleotide was matched to a sequence common to Col and CQ2. The nucleotide se-
quences of all "internal" primers used in this study are given in Table II.
Results
Limited V,8 Gene Segment UsageamongHLA-B27-specific Alloreactive CTL Clones.
￿
The
V(3 gene segments used by 11 human CTL clones obtained, from various responder
individuals, against B*2705 and one clone raised against B*2704 were examined
by PCR. The particular strategy was based on using a set of V(3 family-specific and
one C/3-specific oligonucleotide as primers. With this strategy, specific amplification
was expected only in the aliquot of cDNA from each clone that was incubated with
the appropriate family-specific primer. The specificity of the VO primers was as-
sured by the mismatching with other families and was indicated by the following
criteria: (a) amplification was obtained with all tested T cell clones; (b) the amplified
cDNA was always of the appropriate size, on the basis ofthe expected priming loca-
tions of the V/3 and C(3 primers used; (c) for each clone, bands were only obtained
with one of the V(3 primers (Fig. 1); and (d) sequencing of the amplified material
confirmed in each case that the amplified V(3 gene segment corresponded to the ex-
pected specificity of the primer used (see below).
Fig. 1 shows the PCR amplification of TCR V(3 cDNA from the anti-B27 CTL
clones analyzed in this study. Among thoseclones reactive only with the stimulating
B*2705 subtype (group A), amplification in CTL 67DRF, 212DRD, and 40 was ob-
served with the V014E primer. CTL 17A2 cDNA was amplified with V013E. CTL
G36 cDNA was amplified with the crossreactive l2aE oligonucleotide but not with
V012E or any other Vii family-specific primer. Sequencing of the amplified mate-
rial indicated that this CTL clone also expressed a V013 gene segment (see below).
Amplification of cDNA from CTL 64DRF and 102DRF was obtained with V04E.
By this criterium the two CTL clones from group B, CTL 5A2 and GM7, expressed
V015 and V(33 gene segments, respectively, and those from group C, CTL 28 and
172 DRF, both expressed V04. cDNA from the anti-B*2704 CTL clone 64.8P was
amplified with V07E.
The V(3 families detected among the anti-B*2705 CTL clones fall clearly into two
groups: (a) V04 was observed in 4 of the 11 CTL clones; (b) V03, V013, VA14, and
V015, detected in the remaining seven clones, belong to a group of particularly ho-
mologous families (see Discussion). Interestingly, CTL 64.8P, whose reaction pat-
tern with HLA-B27 subtypes is quite different from those of the anti-B*2705 CTL
clones (Table 1), uses a V/3 family that shares little amino acid sequence homologyBRAGADO ET AL .
FIGURE 1 .
￿
VR gene segment usageamonghuman HLA-B27-specific alloreactiveCTL clones,
as detected by Southern blot analysis of PCR-amplified cDNA . Foreach clone, cDNA aliquots
were subjected to PCR using, in parallel reactions, each of 20 TCR VRE family-specific and
a common C,#E primer (Table 11) . Lanes I-20 in each autoradiogram contain cDNA samples
assayed for amplification with VfllE to V020E, respectively, and hybridized with 12P-labeledCol
oligonucleotide. Thus, the location of radioactive spots indicates the V,Q family amplified from
each T cell clone. For CTL G36, the crossreactive 12aE primer (see Materials and Methods)
was used instead of Vfl12E; as in previous experiments (not shown), no amplification was ob-
tained with any of the family-specific primers . This clone expresses a new V 1613 segment (see
text) .Thedouble bands seen in some cases probably correspond to amplified double- and single-
stranded cDNA . This could arise from unbalance in the two primers used in the PCR, as a result
ofinaccuracies in the spectrophotometric quantitation ofoligonucleotides differing widely in base
content . Dots at both sides ofeach autoradiogram correspond to molecular weight markers (1-kb
DNA ladder; Bethesda Research Laboratories) of 2,036, 1,635, 1,016, 516/506, 394, 344, 298,
220, and 200 bp, respectively. Autoradiograms are grouped according to the reaction patterns
of the CTL clones with HLA-B27 subtypes (Table 1) .
11931194
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TABLE I
Reaction Patterns of Alloreactive CTL Clones with HLA-B27 Subtypes
* The amino acid sequence positions in which each B27 subtype differs from
B*2705 (20) are given in parentheses.
( + ) > 25% specific cytotoxicity at an ET ratio of 4:1 ; (-) absence of cyto-
toxicity (<10%) at the same E/T ratio.
f This clone crossreacted weakly with HLA-B40*(B*4002).
(-20-30%)with those from the anti-B*2705 CTL clones. In addition, in eight CTL
clones not reactive with HLA-B27, which were obtained from the same donors as
theanti-B*2705 clones, a differentset ofV0 families wasdetected (not shown). These
included V02 (CTL M42), V05 (CTL G21, 14DRD and 17DRD), V08 (CTL
166DRF and 1DRD), andV013 (CTL 55DRFand 223DRD), which are not related
to each otherby specially high homology. Taken together, these results indicate that
the anti-B*2705 CTL clones analyzed use a selective subset of V(3 segments.
Sequence Analysis ofAmplified V,QcDNA Reveals Only CorrectlyRearranged V,B Genes and
Detects New V#Members. Double-stranded cDNA amplifiedfromeach anti-B27 CTL
clone was subjected to asymmetric PCR. Both DNA strandswere separately amplified
and sequenced in allcases. The span ofeach sequence was determined by the loca-
tionofthecorrespondingV(3 primers used, andthiswas different fordifferent fami-
lies. However, partial Vl segment sequences, spanning approximately their second
halfin most cases, as well as complete junctional andJO segment sequences, were
obtained from all CTL clones (Fig. 2 A). The V(3 segment sequences allowed us
tounambiguouslyestablish theV(3family used in all cases. In addition, the priming
location of the C/3-derived oligonucleotide allowed us to establish the precise Ca
gene used on the basis of the partial C(3 sequence obtained (Fig. 2).
All sequences correspond to V0 gene material and were always translatable to
amino acid sequences. This indicates that: (a) the PCRamplified material was VO
cDNA; and (b) no evidence for amplification ofaberrant transcripts was obtained.
Whether this is due to the fact that these clones only produced correct rearrange-
ments, or to the inability ofthis technique to detect aberrant V/3 transcripts, was
not examined.
Reaction
pattern
CTL
clone B*2705
B*2701
(74,77,
81)*
B*2702
(77,80,
81)
B*2703
(59)
B*2704
(77,152)
B*2706
(77,114,
116,152)
A 67DRF + 1 - - -
212DRD + - - -
40 + - - -
G36 + - - -
17A2 + - - -
64DRF + - - -
102DRF4 + - - -
B 5A2 + - - +
GM7 + - - +
C 172DRF + - + -
28 + - + -
64.8P + + + - + +yr
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FIGURE 2.
￿
Sequence of TCR VO genes used by 12 humanHLA-B27-specific CTL clones. (A)
Nucleotide anddeducedaminoacid sequencesofspecifically amplifiedVS cDNA from each CTL
clone. Partial VS segment and complete N + D region andJO segment sequences are given.
The breaks in the nucleotide sequence indicate junctional boundaries. V segment boundaries
are assigned as in Wilson et al. (5). JO segment boundaries are considered to be the breaking
pointof identity with the germ-linesequence. TheCDR2 equivalent spanscodons 4-16, referred
to as the determined sequence of CTL 67DRF; the CDR3 equivalent spans thejunctional re-
gion, whichvaries in size amongTcell clones (for assignment ofCDRequivalents, see reference
6). Sequencesare groupedaccordingto thereaction patterns of the correspondingT cell clones
with HLA-B27 subtypes. (B) Assignment of the VO, J(3, and CO gene segments used by each
T cell clone was made on the basis of homology with known sequences. The fourth and fifth
C(3triplets allow distinguishing betweenC/31 andCS2. D,61.1 segments were assigned to allclones
usingJp1 segments on the basis of the requirements for gene rearrangement. All other D/3 as-
signmentswere based, when possible, on sufficient homology with germ-linesequences(30). These
sequence data have been submittedto the EMBL/GenBank Data Libraries under the following
accession numbers: X51785(CTL 102DRF); X51786(CTL 172DRF); X51787(CTL 17A2);
X51788(CTL 212DRD);X51789(CTL 28); X51790(CTL 40); X51791(CTL 5A2); X51792(CTL
64.8P); X51793(CTL 64DRF); X51794(CTL 67DRF); X51795(CTL G36);X51796(CTL GM7).
The V(3 gene segment sequences obtained were identical in most, but not all, cases
to previouslyreported sequences. This allowed formal confirmation ofthe V(3 family
used by each CTL clone, as assigned on the basis of hybridization of the PCRamplified1196
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material (Fig. 1). However, for CTL G36 and 17A2, the sequences obtained were
different from those of known V(3 segments. Both were assigned as V013 members
on the basis of their homology with other sequences from this family (26-28). The
V(3 segment from CTL G36 was sequenced in its last 50 triplets. It differed from
known V013 members by 12-14% of the nucleotide sequence in this region. Such
disparity suggests that failure to amplify V/3 cDNA from this clone with the V013E
primer could be due to sequence differences in the relevant priming site. This was
not formally established because the sequence obtained did not include the priming
location of V013E. Similarly, the last 46 triplets of the V/3 segment from CTL 17A2
were determined and shown to differ from known V013 sequences by at least 5%
and as much as 17 % over this region (Fig. 3). Thus, homology between the partial
V(3 segment sequences from CTL G36 and 17A2 with other V013 sequences is com-
parable with the homology with each other, which is 88% (Fig. 3 and Table III) .
These data indicate that both clones express new, hitherto undescribed, V(3 segments.
Most likely, these are new V013 members, although their definitive family assign-
ment would require determining their complete sequences. Homology of these V/3
segments with members of the highly homologous V012 family ranged from 72 to
75% over the determined regions. We have adopted a convention of 20 V(3 families
(5), but fusing V012 and V013 has been proposed (29).
The nucleotide and amino acid sequence homology among the VO segments from
the anti-B*2705 CTL clones analyzed was compared in Table III through the regions
whose sequence was determined. The data show that the V03, V013, V014, and
V015 segments expressed by these clones share nucleotide sequence homologies ranging
from 58 to 100% over the sequenced regions, as the V014 sequences obtained were
identical (Fig. 2 A). This is in agreement with the overall homology among members
of these related families (5) . The four identical V,64 sequences obtained share a clearly
lower homology (Table 111) with members of the above mentioned V/3 families, also
in agreement with global homology figures. The V07 sequence from CTL 64.8P
is not particularly related to any ofthe V(3 sequences from anti-B*2705 CTL clones.
HLA-B27-specific CTL Clones Display Wide, but not Unrestricted, 14,6Junctional andj,8
SegmentDiversity. As shown in Fig. 2 A, the rearranged /3 genes differ both in length,
ranging from three to nine codons, and sequence at the VDJ junctions. The exact
identification of the D/3 segments used was not always possible (Fig. 2 B), due to
difficulties arising from the combined effects of junctional and N-region diversity
with the small number ofbases making up the germ-line D/3 segments (30). In general,
no common structural motives are apparent in this region, except that five of the
seven clones from group A (B*2705 specific) use Ala codons at the DJ junction.
No CTL clones from other groups use such codons at this point (Fig. 2 A) .
J/3 segment usage is also diverse (Fig. 2) . However, some clones share identical
J/3 segments. First, CTL 64DRF and 28 express the same V04 and identically rear-
ranged Ja2.1 segments. Second, CTL G36 and 17A2 express highly homologous
V(313 and identically rearranged J01.1 segments. Third, CTL 40 and 5A2, which
express significantly homologous V014 and V015 segments (Table III), both express
J,62.3 segments. In this case, both JO segments start at the same Asp codon, thus
having identical amino acid sequences, but that from CTL 40 was apparently rear-
ranged with two additional bases at its 5' end (Fig. 2 A). CTL 172DRF and GM7,
which possess the little homologous V04 and V03 segments, respectively (Table III),BRAGADO ET AL .
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TABLE II
Oligonucleotide Primers for Specific PCR Amplification of TCR V,6 cDNA
External
Sequence
TTT TGG GTG TGG GAG ATC TC
Name
Internal
Sequence
CSI TTC TGA TGG CTC AAA CAC
both express J02.7 segments, but they are differently rearranged, so that the one
from CTL GM7 is two codons larger. Furthermore, thisJ02.7 segment has a T to
G nucleotide change in its sixth codon (GTC instead of TTC), resulting in a Phe
to Val change (Fig. 2A), as compared with the published germ-lineJ02.7 sequence
(30). Thissubstitutionwas confirmedin anindependent RNA preparationandspecific
PCR amplification from the sameCTLclone, suggestingthat an artifactual introduc-
tion ofthis change during sample processing was unlikely. It might reflect a genetic
polymorphism, as also suggested for the D02.1 segment (26), since the two clones
expressing Ja2.7 came from different individuals.
It is interesting that the Jag segments used by the anti-B*2705 CTL clones are
eitherJ02.1,Ja2.3,JS2.5, orJ#2.7 (Fig. 2). Thesehave aProcodonat apolymorphic
position around their middle, which is different in all otherJag segments (30). In
contrast, the anti-B*2704 CTL clone 64.8PexpressedJ02.6, lackingthisPro codon.
The possible significance ofthis structural motiffor the specificity ofthe anti-HLA-
B27 clones is unclear, asthecombined usage ofJ02.1/2.3/2.5/2.7 in nonspecifichuman
T cell populations may be more frequent than that ofthe remainingthreeJ02 seg-
ments (29).
Discussion
Analysesofepitope structure andTCR usage inalloantigen-specific T cell recog-
nition are faced with the extraordinary diversity of alloreactive responses. For in-
5' 3'
VSIE TCC CCT AGG TCT GGA GAG CTC TCT
2E TTT CAG GCC ACA ACT ATG TTT TG 5' 3'
3E GAT ATG GAG CAT GAA AAT ATG TTC VS3I AAA ATG AAA GAA AAA GGA GAT
4E ACG ATC GAG TGT CAA GTC GA 41 CTG ATC GCA ACT GCA AAT GAG
5E CTG ATC AAA ACG AGA GGA CAG CA
6E TCA GGT GTG ATC CAA TTT C
7E CAA CAT ATG GGG CAC AGG GCA ATG 71 TTC TCA CCT GAA TGC CCC AAC
8E GAG GTC ACA GAG ATG GGA CA
9E GAA CAA AAT CTG GGC CAT GAT ACT
10E GTT CCT ATA AAA GCA CAT AGT TAT
11E TCT CAA ACC ATG GGC CAT GAG AAA
12E CTG AGA TGT CAC CAG ACT GAG
12aE CTG GTA TCG ACA AGA CCC
13E GCA TGA CAC TGC AGT GTG CCC 131 TCA TTA CTC AGT TGG TGC TGG
14E ACC CAA GAT ACC TCA TCA CAG 141 AAC AGT GAG TTG TTC TCA GA
15E TCT CAG ACT AAG GGT CAT GAT AGA 151 TTT GAT GTC AAA GAT ATA AAC
16E GAG CCA ATT TCT GGA CAT GAT AAT
17E GAA CAG AAT TTG AAC CAC GAT GCC
18E AGC CCA ATG AAA GGA CAC AGT CAT
19E ACC CCC GAA AAA GGA CAT ACT TTT
20E GAG GGA ACA TCA AAC CCC AAC CTABRAGADO ET AL.
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TABLE III
Homology Matrix of the V,B Gene Segmentsfrom
Anti-HLA-B*2705 CTL Clones
The partial V,8 segment sequences obtained in this study were compared with
each other at both the nucleotide and the amino acid levels. Numbers above and
below the diagonal indicate percentage nucleotide and amino acid sequence ho-
mology, respectively, from any two V,O segments. In comparisons involving iden-
tical VO sequences determined at various lengths from different clones (V(34 and
V014), all combinations were calculated and the means are given. Figures do
not reflect exactly overall V/3 segment homology, as partial sequences are
compared.
stance, virtuallyall CTLclones amenable toanalysis, amongthosegenerated against
HLA-A2 (8, 9) or HLA-1327 (10), possess different fine specificities. In addition, in
the human system, difficulties in growingsufficient cells from most CTLclones seri-
ouslyhamperstudiesatthe clonal level. The existence ofmultiple members in many
TCRVa and V/3 families adds furthercomplication to the system. Wehaveattempted
to circumvent these difficulties in addressing TCR usage in alloreactive responses
against HLA-1327 by using: (a) CTL clones of well characterized fine specificity;
and (b) a PCR strategy that enabled us to establish the use ofVa gene segments
and the complete structure of the V-DJjunctions andJO segments, starting from
very low cell numbers.
Most ofthe 11 anti-B*2705 clones analyzed were different in panel analyses with
site-specific HLA-1327 mutants, but they showed only three reaction patterns with
HLA-1327 subtypes (Table I). Thus, they represented a defined subset ofthe clonal
allospecificities generated against B*2705.
The PCR strategy used has some advantages over that of anchored PCR (31).
First, it simplifies manipulation, as it avoids restriction enzyme and ligase treatments,
as well as transformation and selection ofbacterial colonies. Second, the specificity
ofthe VO primers allows a fast and reliable assignment of the VO segment used,
before sequencing. Third, since direct sequencing eliminates the requirement to
clone amplified cDNA, the probability ofdetecting misincorporated nucleotides is
verymuch decreased, as theentire amplified product is sequenced (24). A disadvan-
67DRF
212DRD
40
(Vp14)
G36
(Va13)
17A2
(VS13)
5A2
(VO15)
GM7
(V03)
64DRF
102DRF
28
172DRF
(V04)
67DRF
212DRD (Vp14) - 67 69 70 79 38
40
G36 (Va13) 64 - 88 61 71 33
17A2 (Vp13) 59 76 - 58 68 35
5A2 (Vs15) 52 52 48 - 75 33
GM7 (V03) 67 63 57 60 - 38
64DRF
102DRF
(Vg4) 24 23 24 21 27
28
172DRF1200
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tage with respect to anchored PCR is that, because of the specificity requirements
of theV0 family-specificprimers, only partial VO segment sequences are obtained.
However, these are sufficient forunambiguousV/3family assignment and, as shown
in this study, for the definition of new VO sequences.
Three V013 sequences have been determined and four V013 members were sug-
gested by sequence and Southern blot analysis (26-28). In contrast to all other V/3
segments in this study, the two V013 segments show hitherto undescribed sequences.
This indicatesthat the V013 family includes at least five members and suggests that
it may be larger.
The structures of the VO genes expressed by the CTL clones examined present
three main features; (a) limited use of V(3 segments; (b) great junctional diversity;
and (c) wide, but not totally unrestricted, use ofJa segments.
Amino acid sequence homology among members of different VO families ranges
from 15 to 60%, with homologies of -25-35% being most frequent (26, 28). How-
ever, virtually all known members of the VR3, V012 to V015, and V019 families
share >50% amino acid sequence homology. Indeed, merging V013 and V014 with
V012 and V03, respectively, has been proposed (29). In contrast with unrelated T
cell clones, 7 of the 11 anti-B*2705 CTL clones examined express one member of
this group ofrelated families, whereas the remainingfour clones express apparently
identical V04 segments. This clearly indicates a nonrandom restriction in Va seg-
ment usage amongthese clones. This cannot be ascribed to limitations in the reper-
toire of CTL precursors from a particular individual because the CTLclones were
derived from various unrelated donors. It is likely that the restriction is imposed
by the stimulator alloantigen, either directly by its structure, or indirectly, through
putative peptides that HLA-B27 might present to alloreactive T cells. Hypothetical
models predict that hypervariable regions encoded in the V gene segments would
interact mainly with residues from the MHC molecule (3). This does not imply a
strict correlation between particular V segments and MHC molecules, but it ex-
plains that a given alloantigen might show some preference for V segment subsets,
as suggested by this study. In addition, it is conceivable that only some of the puta-
tive peptides bound to HLA-B27 may be recognized by the clones that we have ex-
amined. Such peptides could also be involved in the restricted V,6 segment expres-
sion observed, because the last residues of these segments actually are part of the
CDR3-equivalent region, predicted to interact with peptide. Preferential use ofcer-
tain Vsegments has been repeatedly reported in antigen-specific, self-MHC-restricted
responses (32-36), suggesting that particular combinations of MHC plus peptide
may bias V segment usage.
The relatively strict limitation of V/3 segments observed among the selected set
of clones examined may not apply to the whole anti-HLA-B27 CTL response.
Nevertheless, it appears that some correlation could exist between thefine specificity
of alloreactive CTL clones and the V/3 segments that they express. The preciseterms
ofsuch correlation require furtherdefinition. Forinstance, CTL clones within groups
B and C share either identical or related V(3 gene segments, but those in group A
include both related V013 and V014 segments, andthe more distinct V04 (Fig. 2).
In their reactivity with site-specific mutants (10), no more similarity was apparent
among CTL clones with the same or relatedV/3 segments than with those of struc-
turally more distant ones. Further characterization of their fine specificity mightBRAGADO ET AL.
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reveal new similarities among some ofthese clones. The contribution ofother TCR
elements should also be borne in mind.
This is, to our knowledge, the first structural analysis of rearranged TCR genes
among human T cell clones in specific responses. Skewed V segment use among
alloreactive T cells has also been observed in the mouse (25, 37-39), but very few
V gene sequences were reported in these studies (25).
The great variability at the VO-DOJOjunction among the CTL clones examined
is not surprising, as much TCR a chain diversity accumulates in this region. This
diversitycouldbecorrelated with the variability ofepitopesrecognized bytheseclones,
as detected with site-specific mutants, by assuming that different TCRs bind the
sameMHC molecule, orthe same MHC-peptide complex, in differentways. Alter-
natively, it couldbe related to a corresponding multiplicity ofbound peptides. Both
alternatives are not mutually exclusive, as thepredicted surface ofthe MHC-peptide
complexislargeenough toallowTCR bindingindifferentregisters (3). Subtle similar-
itiesare sometimes found inthe V/3D#Jajunction amongrelated T cellclones (40,
41). A conserved residue in this areafrom cytochrome c-specific Tcell clones is crit-
ical for specificity(42). Thus, thefact that five ofthe seven anti-B'2705 CTL clones
in group A (Table 1) possess Ala codons at the D-J junction might be significant
regarding the fine specificity of these clones.
The observed associations of identical or highly homologous Va segments with
the sameJ# segments could also reflect similar specificity, as they occurfrequently
among related T cell clones (40, 41, 43). However, such putative similarity has not
been revealed by the fine specificity analysis ofthese clones. Alternatively, these as-
sociations, and the presence ofonly certainJag segments among the T cell clones
examined, might reflect preferential expression ofcertain V-J combinations due to
selection occurring before antigen stimulation (44). Further analysis is required to
establish this point.
Inconclusion, thedata suggest thatT cellclones activatedin the alloreactive CTL
response against HLA-B27 use a nonrandom subset ofTCR Va segments, coupled
to great variability at thejunctional regions. This variability, however, is somewhat
limited by the existence of a common structural motif at the D-J junction among
somerelated CTL clones and by theassociation ofthe sameJO segment to identical
orparticularly related Va segments in some instances. Besides the preferential use
ofcertainindividual Vgene families,emphasized inmost previous studies, ourresults
suggest that a more subtle selectivity may operate in recognition of MHC mole-
cules, namely, that ofgroups ofparticularly homologous Va families. It is tempting
to speculate that this additional level of selectivity could also influence intrathymic
modulation of the T cell repertoire by self-MHC antigens.
This study suggests that diversity in alloreactive responses can be rationalized by
molecular analysis. Further understanding of the extent and rationale of V gene
usageinthese responseswould requireexaminingVgene structures fromallospecific
T cell clones with a wide range of well characterized fine specificities. It is likely
that such correlation will enlighten our concepts on alloreactivity.
Summary
A strategy, based on usingVa family-specific oligonucleotides, was developed for
specific amplification and direct sequencing of human TCR Va genes. With this1202
￿
T CELL RECEPTOR USAGE IN HUMAN IMMUNE RESPONSES
strategy, it was possible to undertake a structural analysis of TCRs from human
T cell clones in specific responses. 12 HLA-B27-specific cytotoxic clones were exam-
ined. The results reveal a nonrandom use of V0 gene diversity in this alloreactive
response in that: (a) the clones express a restricted number of V(3 segments, including
a subset of Va families that are significantly more related to one another than to
most other Va families; (b) five of seven clones having a particular reaction pattern
with HLA-B27 subtypes possess Alanine at the D-J junction; and (c) identical J/3
segments are found associated in several instances with identical or highly homolo-
gous V/3 gene segments. In addition, two new V013 members are reported.
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